DK494689A - Peptidaseinhibitorer - Google Patents

Peptidaseinhibitorer Download PDF

Info

Publication number: DK494689A
Authority: DK; Denmark
Prior art keywords: alpha; amino acid; group; peptidase; alkyl
Prior art date: 1988-10-07

Application number

DK494689A

Other languages

English (en)

Other versions

DK494689D0 (da

Inventor

Philippe Bey

Michael Angelastro

Shujaath Mehdi

Original Assignee

Merrell Dow Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-10-07

Filing date

1989-10-06

Publication date

1990-04-08

1989-10-06 Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma

1989-10-06 Publication of DK494689D0 publication Critical patent/DK494689D0/da

1990-04-08 Publication of DK494689A publication Critical patent/DK494689A/da

Links

102000035195 Peptidases Human genes 0.000 title abstract 5
108091005804 Peptidases Proteins 0.000 title abstract 5
235000019833 protease Nutrition 0.000 title abstract 4
235000008206 alpha-amino acids Nutrition 0.000 abstract 7
150000001370 alpha-amino acid derivatives Chemical class 0.000 abstract 5
108090000765 processed proteins & peptides Proteins 0.000 abstract 4
239000000758 substrate Substances 0.000 abstract 4
102000004190 Enzymes Human genes 0.000 abstract 2
108090000790 Enzymes Proteins 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
125000003710 aryl alkyl group Chemical group 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
229910052757 nitrogen Inorganic materials 0.000 abstract 2
125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
125000006239 protecting group Chemical group 0.000 abstract 2
125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
125000003161 (C1-C6) alkylene group Chemical group 0.000 abstract 1
125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract 1
101100294106 Caenorhabditis elegans nhr-3 gene Proteins 0.000 abstract 1
239000004365 Protease Substances 0.000 abstract 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
150000001371 alpha-amino acids Chemical class 0.000 abstract 1
125000003368 amide group Chemical group 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000002532 enzyme inhibitor Substances 0.000 abstract 1
150000004677 hydrates Chemical class 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
125000000346 malonyl group Chemical group C(CC(=O)*)(=O)* 0.000 abstract 1
239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Crystallography & Structural Chemistry (AREA)
Immunology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Detergent Compositions (AREA)
Enzymes And Modification Thereof (AREA)

DK494689A 1988-10-07 1989-10-06 Peptidaseinhibitorer DK494689A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US25476288A	1988-10-07	1988-10-07

Publications (2)

Publication Number	Publication Date
DK494689D0 DK494689D0 (da)	1989-10-06
DK494689A true DK494689A (da)	1990-04-08

Family

ID=22965502

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK494789A DK494789A (da)	1988-10-07	1989-10-06	Peptidaseinhibitorer
DK494689A DK494689A (da)	1988-10-07	1989-10-06	Peptidaseinhibitorer

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK494789A DK494789A (da)	1988-10-07	1989-10-06	Peptidaseinhibitorer

Country Status (18)

Country	Link
EP (2)	EP0364344B1 (da)
JP (2)	JP3203579B2 (da)
KR (2)	KR900006363A (da)
CN (2)	CN1041951A (da)
AT (2)	ATE165835T1 (da)
AU (1)	AU617875B2 (da)
CA (2)	CA2000342C (da)
DE (2)	DE68928042T2 (da)
DK (2)	DK494789A (da)
ES (2)	ES2103709T3 (da)
FI (2)	FI894747A7 (da)
GR (1)	GR3024158T3 (da)
HU (2)	HU895246D0 (da)
IL (2)	IL91895A0 (da)
NO (2)	NO894013L (da)
NZ (2)	NZ230893A (da)
PT (2)	PT91927B (da)
ZA (2)	ZA897515B (da)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5510531A (en) *	1989-04-10	1996-04-23	Suntory Limited	Proteinase inhibitor
EP0672648B1 (en) *	1989-04-15	1998-09-23	Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai	Threo (2R,3S)-3-amino-2-hydroxypentanoic acid and threo (2R,3S)-3-(p-methoxy-benzyloxycarbonyl/FMOC) amino-2-hydroxy-pentanoic acid
AU661270B2 (en) *	1990-03-05	1995-07-20	Cephalon, Inc.	Chymotrypsin-like proteases and their inhibitors
GB9019558D0 (en) *	1990-09-07	1990-10-24	Szelke Michael	Enzyme inhibitors
US5444042A (en) *	1990-12-28	1995-08-22	Cortex Pharmaceuticals	Method of treatment of neurodegeneration with calpain inhibitors
JPH06504547A (ja) *	1990-12-28	1994-05-26	ジョージア・テック・リサーチ・コーポレーション	ペプチドケトアミド、ケト酸およびケトエステル
WO1992020357A1 (en) *	1991-05-23	1992-11-26	Merrell Dow Pharmaceuticals Inc.	Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
CA2071621C (en) *	1991-06-19	1996-08-06	Ahihiko Hosoda	Aldehyde derivatives
US6235929B1 (en)	1991-12-27	2001-05-22	Georgia Tech Research Corporation	Tripeptide α-ketoamides
US5610297A (en) *	1991-12-27	1997-03-11	Georgia Tech Research Corp.	Peptides ketoamides
US5514694A (en) *	1992-09-21	1996-05-07	Georgia Tech Research Corp	Peptidyl ketoamides
DE69414279T2 (de) *	1993-02-09	1999-04-08	Bayer Corp., Pittsburgh, Pa.	Sulfonamidaminomethylenderivate als Immunsuppressiva
US5672582A (en) *	1993-04-30	1997-09-30	Merck & Co., Inc.	Thrombin inhibitors
US6984627B1 (en)	1993-06-03	2006-01-10	Astrazeneca Ab	Peptide derivatives
US5783563A (en) *	1993-06-03	1998-07-21	Astra Aktiebolag	Method for treatment or prophylaxis of venous thrombosis
SE9301916D0 (sv) *	1993-06-03	1993-06-03	Ab Astra	New peptides derivatives
US5541290A (en) *	1993-06-24	1996-07-30	Harbeson; Scott L.	Optically pure calpain inhibitor compounds
EP0639585A1 (en) *	1993-08-20	1995-02-22	Banyu Pharmaceutical Co., Ltd.	Elastase inhibitor
US5977074A (en) *	1993-10-01	1999-11-02	Merrell Pharmaceuticals, Inc.	Inhibitors of β-amyloid protein production
IT1270882B (it) *	1993-10-05	1997-05-13	Isagro Srl	Oligopeptidi ad attivita' fungicida
US6060462A (en) *	1993-10-20	2000-05-09	Dupont Pharmaceuticals Company	Electrophilic peptide analogs as inhibitors of trypsin-like enzymes
US5486623A (en)	1993-12-08	1996-01-23	Prototek, Inc.	Cysteine protease inhibitors containing heterocyclic leaving groups
US5693617A (en) *	1994-03-15	1997-12-02	Proscript, Inc.	Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
US6660268B1 (en)	1994-03-18	2003-12-09	The President And Fellows Of Harvard College	Proteasome regulation of NF-KB activity
DE4421052A1 (de)	1994-06-17	1995-12-21	Basf Ag	Neue Thrombininhibitoren, ihre Herstellung und Verwendung
DE4421884A1 (de)	1994-06-23	1996-01-04	Hoechst Ag	Verfahren zur Herstellung von Hydroxycarbonsäureaniliden
US5510369A (en) *	1994-07-22	1996-04-23	Merck & Co., Inc.	Pyrrolidine thrombin inhibitors
DE4427837A1 (de)	1994-08-05	1996-02-08	Hoechst Ag	Verfahren zur Herstellung von O-Acylglykolsäureaniliden
US6083903A (en)	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
SE9404196D0 (sv) *	1994-12-02	1994-12-02	Astra Ab	New antithrombotic formulation
US6017887A (en) *	1995-01-06	2000-01-25	Sibia Neurosciences, Inc.	Peptide, peptide analog and amino acid analog protease inhibitors
US5804560A (en) *	1995-01-06	1998-09-08	Sibia Neurosciences, Inc.	Peptide and peptide analog protease inhibitors
US5691368A (en) *	1995-01-11	1997-11-25	Hoechst Marion Roussel, Inc.	Substituted oxazolidine calpain and/or cathepsin B inhibitors
NO315930B1 (no)	1995-01-18	2003-11-17	Picower Inst For Medical Res T	Anvendelse av tiazoliumforbindelser ved fremstilling av farmasöytiske preparater, preparater som inneholder forbindelsene, samt nyetiazoliumforbindelser
US5656261A (en)	1995-01-18	1997-08-12	The Picower Institute For Medical Research	Preventing and reversing advanced glycosylation endproducts
EP1327887A3 (en) *	1995-01-18	2008-12-10	Synvista Therapeutics, Inc.	Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation end products
DE19504225A1 (de)	1995-02-09	1996-08-14	Hoechst Ag	Verfahren zur Herstellung von O-Acyloxycarbonsäureaniliden
CZ245797A3 (cs) *	1995-02-17	1998-06-17	Basf Aktiengesellschaft	Derivát amidinu dipeptidu jako inhibitor thrombinu
US5629324A (en) *	1995-04-10	1997-05-13	Merck & Co., Inc.	Thrombin inhibitors
US5721214A (en) *	1995-06-07	1998-02-24	Cor Therapeutics, Inc.	Inhibitors of factor Xa
US6211154B1 (en)	1995-06-07	2001-04-03	Cor Therapeutics, Inc.	Ketoheterocyclic inhibitors of factor Xa
US6069130A (en) *	1995-06-07	2000-05-30	Cor Therapeutics, Inc.	Ketoheterocyclic inhibitors of factor Xa
US5919765A (en) *	1995-06-07	1999-07-06	Cor Therapeutics, Inc.	Inhibitors of factor XA
US6046169A (en) *	1995-06-07	2000-04-04	Cor Therapeutics, Inc.	Inhibitors of factor XA
US6022861A (en) *	1995-06-07	2000-02-08	Cor Therapeutics, Inc.	Ketoheterocyclic inhibitors of factor Xa
SA96170106A (ar) *	1995-07-06	2005-12-03	أسترا أكتيبولاج	مشتقات حامض أميني جديدة
US5827877A (en) *	1995-09-14	1998-10-27	Cephalon, Inc.	Ketomethylene group-containing cysteine and serine protease inhibitors
US5723580A (en) *	1995-09-14	1998-03-03	Cephalon, Inc.	Ketomethylene group-containing aldehyde cysteine and serine protease inhibitors
US5763576A (en) *	1995-10-06	1998-06-09	Georgia Tech Research Corp.	Tetrapeptide α-ketoamides
AU709088B2 (en) *	1995-10-24	1999-08-19	Merck & Co., Inc.	Thrombin inhibitors
EP0910564B1 (en) *	1995-11-28	2007-10-31	Cephalon, Inc.	D-amino acid derived inhibitors of cysteine and serine proteases
TWI238827B (en)	1995-12-21	2005-09-01	Astrazeneca Ab	Prodrugs of thrombin inhibitors
US6245743B1 (en)	1996-06-05	2001-06-12	Cor Therapeutics, Inc.	Inhibitors of factor Xa
SE9602263D0 (sv)	1996-06-07	1996-06-07	Astra Ab	New amino acid derivatives
SE9602646D0 (sv)	1996-07-04	1996-07-04	Astra Ab	Pharmaceutically-useful compounds
US5792761A (en) *	1996-08-12	1998-08-11	Merck & Co., Inc.	Thrombin inhibitors
BR9712000A (pt) *	1996-09-06	1999-08-24	Nippon Kayaku Kk	Derivados de acetamida sais dos mesmos composi-Æo farmac-utica inibidores de protease de quimase de desgranula-Æo de mastÄcitos ou de libera-Æo de histamina de mastÄcitos e de ativa-Æo de eosinÄfilo ou de libera-Æo de oxig-nio ativo de eosinÄfilo e processo para produzir os dervados de acetamida
AP1019A (en)	1996-10-18	2001-10-16	Vertex Pharma	Inhibitors of serinre proteases, particularly hepatitis C virus NS3 protease.
SI0932617T1 (en) *	1996-10-18	2002-06-30	Vertex Pharmaceuticals Incorporated	Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
US5798377A (en) *	1996-10-21	1998-08-25	Merck & Co., Inc.	Thrombin inhibitors
DE19648793A1 (de)	1996-11-26	1998-05-28	Basf Ag	Neue Benzamide und deren Anwendung
AU6134498A (en) *	1997-03-07	1998-09-22	Hoechst Marion Roussel, Inc.	Method of treating trauma associated with brain, spinal cord or peripheral nerveinjury using carbobenzyloxy n-protected di- and tripeptide phenylalaninals
AR013084A1 (es)	1997-06-19	2000-12-13	Astrazeneca Ab	Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
TWI222441B (en)	1997-11-26	2004-10-21	Dimensional Pharm Inc	Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
US6204384B1 (en)	1997-11-26	2001-03-20	Corvas International, Inc.	Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors (II)
US6011047A (en) *	1997-11-26	2000-01-04	Corvas International Inc.	Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors
SE9704543D0 (sv)	1997-12-05	1997-12-05	Astra Ab	New compounds
EP1051431A1 (de)	1998-01-26	2000-11-15	Basf Aktiengesellschaft	Thrombininhibitoren
AU766219B2 (en)	1998-02-02	2003-10-09	1149336 Ontario Inc.	Method of regulating glucose metabolism, and reagents related thereto
JP4554077B2 (ja)	1998-06-11	2010-09-29	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	ピラジノンプロテアーゼインヒビター
SE9804313D0 (sv)	1998-12-14	1998-12-14	Astra Ab	New compounds
EP1150996B1 (en)	1999-01-13	2007-11-21	AstraZeneca AB	New amidinobenzylamine derivatives and their use as thrombin inhibitors
AR023510A1 (es)	1999-04-21	2002-09-04	Astrazeneca Ab	Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
WO2000073302A1 (en)	1999-05-27	2000-12-07	3-Dimensional Pharmaceuticals, Inc.	Oxazaheterocycles as protease inhibitors
DE60005351D1 (de)	1999-07-09	2003-10-23	Dimensional Pharm Inc	Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel
US6630510B1 (en) *	1999-10-28	2003-10-07	Merck & Co., Inc.	Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
US6809092B2 (en) *	2000-01-26	2004-10-26	Ono Pharmaceutical Co., Ltd.	Benezene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient
SE0001803D0 (sv)	2000-05-16	2000-05-16	Astrazeneca Ab	New compounds i
WO2001092234A1 (en)	2000-06-01	2001-12-06	Merck & Co., Inc.	Pyrazinone thrombin inhibitors
CA2415932A1 (en)	2000-07-17	2002-01-24	3-Dimensional Pharmaceuticals, Inc.	Cyclic oxyguanidine pyrazinones as protease inhibitors
SK742003A3 (en) *	2000-07-21	2003-06-03	Schering Corp	Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
CN1498224A (zh)	2000-07-21	2004-05-19	��鹫˾	用作丙型肝炎病毒ns3-丝氨酸蛋白酶抑制剂的新型肽
US7244721B2 (en)	2000-07-21	2007-07-17	Schering Corporation	Peptides as NS3-serine protease inhibitors of hepatitis C virus
CA2417914A1 (en)	2000-08-04	2002-02-14	3-Dimensional Pharmaceuticals, Inc.	Cyclic oxyguanidine protease inhibitors
US6433186B1 (en)	2000-08-16	2002-08-13	Astrazeneca Ab	Amidino derivatives and their use as thormbin inhibitors
US7129233B2 (en)	2000-12-01	2006-10-31	Astrazeneca Ab	Mandelic acid derivatives and their use as thrombin inhibitors
AR035216A1 (es)	2000-12-01	2004-05-05	Astrazeneca Ab	Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US6528503B2 (en)	2000-12-18	2003-03-04	Merck & Co., Inc.	Thrombin inhibitors
JP2004516286A (ja)	2000-12-18	2004-06-03	メルクエンドカムパニーインコーポレーテッド	ベンジルアミン誘導体およびそれのトロンビン阻害薬としての使用
US6610701B2 (en)	2001-02-09	2003-08-26	Merck & Co., Inc.	Thrombin inhibitors
CA2436176A1 (en)	2001-02-09	2002-08-22	Merck & Co., Inc.	Thrombin inhibitors
AR034517A1 (es)	2001-06-21	2004-02-25	Astrazeneca Ab	Formulacion farmaceutica
US6777431B2 (en)	2001-07-13	2004-08-17	Corvas International, Inc.	Non-convalent thrombin inhibitors
WO2003045228A2 (en)	2001-11-26	2003-06-05	Trustees Of Tufts College	Methods for treating autoimmune disorders, and reagents related thereto
US7084134B2 (en)	2002-05-02	2006-08-01	Merk & Co., Inc.	Thrombin inhibitors
SE0201659D0 (sv)	2002-05-31	2002-05-31	Astrazeneca Ab	Modified release pharmaceutical formulation
SE0201661D0 (sv)	2002-05-31	2002-05-31	Astrazeneca Ab	New salts
GB0217136D0 (en)	2002-07-24	2002-09-04	Renovo Ltd	Wound healing & treatment of fibrosis
ES2421516T3 (es)	2002-11-06	2013-09-03	Dana Farber Cancer Inst Inc	Composiciones para tratar el cáncer usando el inhibidor de proteasomas PS-341
US20050014747A1 (en)	2003-04-18	2005-01-20	Emily Reinhard	Dihydrothiazine prodrugs of thiazolium agents
US7781424B2 (en)	2003-05-27	2010-08-24	Astrazeneca Ab	Modified release pharmaceutical formulation
UY28500A1 (es)	2003-09-05	2005-04-29	Vertex Pharma	Inhibidores de proteasas de serina, en particular proteasa ns3-ns4a del vhc.
US7795205B2 (en)	2004-04-12	2010-09-14	Canyon Pharmaceuticals, Inc.	Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
WO2007041773A1 (en)	2005-10-07	2007-04-19	Biopharmica Ltd	Sumoylation control agent and uses thereof
EP2036920B1 (en)	2006-01-11	2011-05-18	Seikagaku Corporation	Cycloalkylcarbonylamino acid ester derivative and process for producing the same
JP4047365B2 (ja)	2006-01-11	2008-02-13	生化学工業株式会社	シクロアルカンカルボキサミド誘導体及びその製造方法
JP3975226B2 (ja)	2006-01-11	2007-09-12	生化学工業株式会社	シクロアルキルカルボニルアミノ酸誘導体及びその製造方法
EP2007364A4 (en)	2006-04-07	2009-11-11	Biopharmica Ltd	MODULATOR OF THE TRANSCRIPTION FACTOR
TW200827336A (en)	2006-12-06	2008-07-01	Astrazeneca Ab	New crystalline forms
EP2922535B1 (en)	2012-11-20	2021-11-10	Merck Sharp & Dohme Corp.	Thrombin inhibitors
IL277402B1 (en)	2018-03-20	2026-04-01	Abraxis Bioscience Llc	Methods for treating central nervous system disorders using administration of MTOR inhibitor nanoparticles and albumin

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS4920118A (da) *	1972-06-23	1974-02-22
JPS594415B2 (ja) *	1974-02-18	1984-01-30	帝人株式会社	Ｄ，ｌ−２− アミノ −１− ブタノ−ルノコウガクブンカツホウ
JPS50142505A (da) *	1974-05-08	1975-11-17
HU177098B (en) *	1979-01-04	1981-07-28	Gyogyszerkutato Intezet	Process for producing new peptidyl-n-carboxy-l-arginin-a
JPS55138389A (en) *	1979-04-14	1980-10-29	Denki Kagaku Kogyo Kk	Preparation of amino alcohols
FR2537131B1 (fr) *	1980-04-17	1986-05-09	Roques Bernard	Nouveaux derives d'acides amines et leur application therapeutique
JPS5754157A (en) *	1980-09-19	1982-03-31	Nippon Kayaku Co Ltd	L-argininal derivative and its preparation
JPS58198296A (ja) *	1982-05-12	1983-11-18	Chisso Corp	ｄ−２−アミノブタノ−ルの製造法
WO1984000365A1 (en) *	1982-07-19	1984-02-02	Nat Res Dev	Synthetic peptides and their preparation
EP0124317B1 (en) *	1983-04-27	1990-04-11	Ici Americas Inc.	Proline derivatives
GB8312339D0 (en) *	1983-05-05	1983-06-08	Austen B M	Peptides
FR2546164B1 (fr) *	1983-05-16	1987-07-17	Centre Nat Rech Scient	Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
JPS59227851A (ja) *	1983-06-09	1984-12-21	Sankyo Co Ltd	レニン阻害作用を有するペプチド類
CA1267499A (en) *	1983-07-12	1990-04-03	Cedric H. Hassall	Peptide amides and aldehydes
DK34086A (da) *	1985-01-23	1986-07-24	Abbott Lab	Peptidylaminodioler
ZA86746B (en) *	1985-02-04	1986-09-24	Merrell Dow Pharma	Novel peptidase inhibitors
US4851387A (en) *	1986-10-14	1989-07-25	Banyu Pharmaceutical Co., Ltd.	5-substituted amino-4-hydroxy-pentanoic acid derivatives and their use
MY103189A (en) *	1986-10-31	1993-05-29	Pfizer	Nor-statine and nor-cyclostatine polypeptides
FI89058C (fi) *	1987-02-27	1993-08-10	Yamanouchi Pharma Co Ltd	Foerfarande foer framstaellning av som remin-inhibitorer anvaenda 2-(l-alanyl-l-histidylamino)-butanol-derivat
US4820691A (en) *	1987-06-24	1989-04-11	E. R. Squibb & Sons, Inc.	Amino acid 1,2-diketo derivatives as renin inhibitors
US4913296A (en) *	1988-03-30	1990-04-03	Applied Power Inc.	Storing and dispensing system
DE3827415A1 (de) *	1988-08-12	1990-02-15	Behringwerke Ag	Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung

1989
- 1989-10-03 ZA ZA897515A patent/ZA897515B/xx unknown
- 1989-10-03 ZA ZA897514A patent/ZA897514B/xx unknown
- 1989-10-04 AU AU42491/89A patent/AU617875B2/en not_active Ceased
- 1989-10-04 NZ NZ230893A patent/NZ230893A/en unknown
- 1989-10-05 IL IL91895A patent/IL91895A0/xx unknown
- 1989-10-05 IL IL91896A patent/IL91896A0/xx unknown
- 1989-10-05 NZ NZ230916A patent/NZ230916A/en unknown
- 1989-10-06 PT PT91927A patent/PT91927B/pt not_active IP Right Cessation
- 1989-10-06 AT AT89402763T patent/ATE165835T1/de not_active IP Right Cessation
- 1989-10-06 JP JP26036089A patent/JP3203579B2/ja not_active Expired - Fee Related
- 1989-10-06 DE DE68928042T patent/DE68928042T2/de not_active Expired - Fee Related
- 1989-10-06 FI FI894747A patent/FI894747A7/fi not_active IP Right Cessation
- 1989-10-06 HU HU895246A patent/HU895246D0/hu unknown
- 1989-10-06 ES ES89402762T patent/ES2103709T3/es not_active Expired - Lifetime
- 1989-10-06 AT AT89402762T patent/ATE153029T1/de not_active IP Right Cessation
- 1989-10-06 PT PT91926A patent/PT91926B/pt not_active IP Right Cessation
- 1989-10-06 EP EP89402763A patent/EP0364344B1/en not_active Expired - Lifetime
- 1989-10-06 DE DE68928662T patent/DE68928662T2/de not_active Expired - Fee Related
- 1989-10-06 ES ES89402763T patent/ES2118710T3/es not_active Expired - Lifetime
- 1989-10-06 EP EP89402762A patent/EP0363284B1/en not_active Expired - Lifetime
- 1989-10-06 HU HU895247A patent/HUT54105A/hu unknown
- 1989-10-06 DK DK494789A patent/DK494789A/da not_active Application Discontinuation
- 1989-10-06 JP JP1260361A patent/JPH02134398A/ja active Pending
- 1989-10-06 KR KR1019890014375A patent/KR900006363A/ko not_active Withdrawn
- 1989-10-06 DK DK494689A patent/DK494689A/da not_active Application Discontinuation
- 1989-10-06 FI FI894748A patent/FI894748A7/fi not_active IP Right Cessation
- 1989-10-06 KR KR1019890014374A patent/KR900006362A/ko not_active Withdrawn
- 1989-10-06 NO NO89894013A patent/NO894013L/no unknown
- 1989-10-06 NO NO89894014A patent/NO894014L/no unknown
- 1989-10-07 CN CN89107700A patent/CN1041951A/zh active Pending
- 1989-10-07 CN CN89107699A patent/CN1041950A/zh active Pending
- 1989-10-10 CA CA002000342A patent/CA2000342C/en not_active Expired - Fee Related
- 1989-10-10 CA CA002000340A patent/CA2000340A1/en not_active Abandoned
1997
- 1997-07-18 GR GR970401803T patent/GR3024158T3/el unknown

Also Published As

Publication number	Publication date
DE68928042T2 (de)	1997-08-28
PT91927A (pt)	1990-04-30
NO894014L (no)	1990-04-09
ES2118710T3 (es)	1998-10-01
CA2000340A1 (en)	1990-04-07
ATE153029T1 (de)	1997-05-15
PT91926B (pt)	1995-07-03
NO894013D0 (no)	1989-10-06
FI894748A0 (fi)	1989-10-06
KR900006363A (ko)	1990-05-08
HU895247D0 (da)	1990-01-28
EP0364344A3 (en)	1991-09-11
DK494789A (da)	1990-04-08
DE68928662D1 (de)	1998-06-10
IL91895A0 (en)	1990-06-10
CA2000342A1 (en)	1990-04-07
EP0363284A3 (en)	1992-07-01
DE68928662T2 (de)	1998-11-26
AU617875B2 (en)	1991-12-05
FI894748L (fi)	1990-04-08
EP0363284A2 (en)	1990-04-11
DE68928042D1 (de)	1997-06-19
ATE165835T1 (de)	1998-05-15
ZA897515B (en)	1990-06-27
DK494789D0 (da)	1989-10-06
DK494689D0 (da)	1989-10-06
NZ230893A (en)	1992-01-29
IL91896A0 (en)	1990-06-10
AU4262589A (en)	1990-04-12
FI894747L (fi)	1990-04-08
FI894747A7 (fi)	1990-04-08
NZ230916A (en)	1992-02-25
NO894013L (no)	1990-04-09
CN1041950A (zh)	1990-05-09
AU626918B2 (en)	1992-08-13
KR900006362A (ko)	1990-05-08
EP0364344A2 (en)	1990-04-18
FI894747A0 (fi)	1989-10-06
GR3024158T3 (en)	1997-10-31
JPH02134398A (ja)	1990-05-23
HUT54105A (en)	1991-01-28
PT91926A (pt)	1990-04-30
EP0364344B1 (en)	1998-05-06
ZA897514B (en)	1990-06-27
JPH02256654A (ja)	1990-10-17
JP3203579B2 (ja)	2001-08-27
AU4249189A (en)	1990-06-28
CN1041951A (zh)	1990-05-09
CA2000342C (en)	2000-10-03
EP0363284B1 (en)	1997-05-14
ES2103709T3 (es)	1997-10-01
PT91927B (pt)	1995-07-03
NO894014D0 (no)	1989-10-06
HU895246D0 (en)	1990-01-28
FI894748A7 (fi)	1990-04-08

Legal Events

Date	Code	Title	Description
1993-09-13	ATS	Application withdrawn

Publication	Publication Date	Title
DE68928662D1 (de)	1998-06-10	Peptidase-Hemmer
EP0393457B1 (en)	1994-07-06	Proteinase inhibitor
CO4950618A1 (es)	2000-09-01	Inhibidores de proteasas
MY137301A (en)	2009-01-30	Peptide analogs as irreversible interleukin-1b protease inhibitors
AU4799793A (en)	1994-03-15	Beta -aminoalkyl and beta -n-peptidylaminoalkyl boronic acids
NO934335D0 (no)	1993-11-30	Interlaukin 1-beta protease og interlaukin 1-beta proteaseinhibitorer
GR3030311T3 (en)	1999-09-30	Peptide derivatives of the boronic acid having protease inhibiting activity, process for their production and pharmaceutical compositions comprising them.
ATE251146T1 (de)	2003-10-15	Selektive thrombin-hemmer
ES2053525T3 (es)	1994-08-01	Acidos hidroxamicos.
NO921852D0 (no)	1992-05-11	N-substituerte azaheterosykliske karboksylsyrer og en farmasoeytisk sammensetning
MY155273A (en)	2015-09-30	Selective thrombin inhibitors
MY155271A (en)	2015-09-30	Selective thrombin inhibitors